The bar chart depicts the percentage of drug company’s sales to three regions (America, Europe, and Asia) from 2002 to 2006.
Overall, from 2002 to 2006, sales to America decreased while to Asia, it increased significantly. However, sales to Europe fluctuated simultaneously. Moreover, drug sales to the U.S.A. were the highest in 2002, to Europe in 2004, and to Asia in 2006 while it being lowest to the U.S.A. in 2004, and to Asia in 2002.
Concerning America, the company’s drug sales dropped almost 11% from 2002 to 2006. It started at 41 percent in 2002 after which it fell to 35% in 2003 before being dropped to its lowest to 27 percent in 2004 after which it slightly rose to 30 percent in 2006. On the other hand, sales to Asia increased by almost 15% and rose consecutively in each year starting at 25% in 2002 and ending at 40% in 2006.
However, drug sales to Europe fluctuated starting from 34% in 2002 and jumped to their highest in 2004 to 38% before dropping to its lowest to 30% in 2006.
